Issue Type: Abuses of Government Programs and Regulations

In challenge narrative 12/9/20

  • Xeljanz, the FDA, and nine years of patient harm

  • Atypical antipsychotics: Decades of use, unfathomable harms

  • What A Waste! The National Academy Of Medicine’s Report On Oversized Vials Of Expensive Drugs

  • Medicare Must Study Unproven, Expensive Alzheimer’s Drug

  • Trump’s Drug-Pricing Ideas Would Cost Taxpayers a Bundle

  • CMS’s Proposed Medicaid Best Price Loophole for Value-Based Purchasing of Drugs

  • CMS Announces Delay of MCIT Final Rule

  • Curbing Biologic Drug Spending with P-quad

  • Ethics of Clinical Trials to Evaluate Biosimilars

  • Abuses of Government Programs and Regulations